Medical interventions for acanthamoeba keratitis

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 2, 2015, Pages

  Alkharashi, Majed ^a   Lindsley, Kristina ^b   Law, Hua Andrew ^b   Sikder, Shameema ^c  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE; POLY(HEXAMETHYLENEBIGUANIDE); BIGUANIDE DERIVATIVE; TOPICAL ANTIINFECTIVE AGENT;

ACANTHAMOEBA KERATITIS; DRUG EFFICACY; DRUG SAFETY; EXPERIMENTAL DESIGN; HUMAN; KERATOPLASTY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TREATMENT DURATION; VISUAL ACUITY;

ACANTHAMOEBA KERATITIS; ANTI-INFECTIVE AGENTS, LOCAL; BIGUANIDES; CHLORHEXIDINE; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84934300307     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD010792.pub2     Document Type: Review

References (66)

1. Ficker LA, Fraenckel GE, Dark JK, Larkin DF, Tuft S, Matheson M. Efficacy of chlorhexidine versus PHMB for Acanthamoeba keratitis. Investigative Ophthalmology and Visual Science 1999; Vol. 40:ARVO E-abstract 2894.
2. Lim N, Goh D, Bunce C, Fraenkel G, Poole TR, Ficker LA. Acanthamoeba keratitis monotherapy treatment trial of polyhexamethylene biguanide vs. chlorhexidine. American Academy of Ophthalmology (Special supplement Eye Net, Free papers and posters from the joint meeting of the AAO and SOE, 2004, New Orleans). 2004.
3. Lim N, Goh D, Bunce C, Xing W, Fraenkel G, Poole TR, et al. Comparison of polyhexamethylene biguanide and chlorhexidine as monotherapy agents in the treatment of Acanthamoeba keratitis. American Journal of Ophthalmology 2008;145(1):130-5.
4. Manabe R, Moriyama H, Suda T. A double-blind study of tobramycin eye drops on infectious diseases of anterior portion of the eye. Comparison with gentamicin eye drops. Folia Ophthalmologica Japonica 1981;32(4):1041-65.
5. Peoc'h M, Masella JJ, Romanet JP, Pasquier D, Laverriere MH, Pasquier B. Acanthamoeba keratitis. Presse Medicale 1998;27(4):160-1.
6. Shimada K, Kitano S, Higashino L. A double blind study of DE-020 eye drops in external infections of the eye. Japanese Journal of Clinical Ophthalmology 1979;33:1543-53.
7. Venkataswamy G, Gnanados AS, Bose K. Gentamicin (Genticyn). A clinical trial on 75 cases of eye infections. Indian Medical Gazette 1975;14(12):511-4.
8. Acharya NR, Lietman TM, Margolis TP. Parasites on the rise: a new epidemic of Acanthamoeba keratitis. American Journal of Ophthalmology 2007; Vol. 144, issue 2:292-3.
9. Alizadeh H, Apte S, El-Agha MS, Li L, Hurt M, Howard K, et al. Tear IgA and serum IgG antibodies against Acanthamoeba in patients with Acanthamoeba keratitis. Cornea 2001;20(6):622-7.
10. Alizadeh H, Neelam S, Hurt M, Niederkorn JY. Role of contact lens wear, bacterial flora, and mannose-induced pathogenic protease in the pathogenesis of amoebic keratitis. Infection and Immunity 2005;73(2):1061-8.
11. Awwad ST, Petroll WM, McCulley JP, Cavanagh HD. Updates in Acanthamoeba keratitis. Eye and Contact Lens 2007;33(1):1-8.
12. Biddick CJ, Rogers LH, Brown TJ. Viability of pathogenic and nonpathogenic free-living amoebae in long-term storage at a range of temperatures. Applied and Environmental Microbiology 1984;48(4):859-60.
13. Borin S, Feldman I, Ken-Dror S, Briscoe D. Rapid diagnosis of acanthamoeba keratitis using non-nutrient agar with a lawn of E. coli. Journal of Ophthalmic Inflammation and Infection 2013;3(1):40.
14. Brandt FH, Ware DA, Visvesvara GS. Viability of Acanthamoeba cysts in ophthalmic solutions. Applied and Environmental Microbiology 1989;55(5):1144-6.
15. Butler TK, Males JJ, Robinson LP, Wechsler AW, Sutton GL, Cheng J, et al. Six-year review of Acanthamoeba keratitis in New South Wales, Australia: 1997-2002. Clinical and Experimental Ophthalmology 2005;33(1):41-6.
16. Claerhout I, Goegebuer A, Van Den Broecke C, Kestelyn P. Delay in diagnosis and outcome of Acanthamoeba keratitis. Graefe's Archive for Clinical and Experimental Ophthalmology 2004;242(8):648-53.
17. Dart JK, Radford CF, Minassian D, Verma S, Stapleton F. Risk factors for microbial keratitis with contemporary contact lenses: a case-control study. Ophthalmology 2008;115(10):1647-54.
18. Dart JK, Saw VP, Kilvington S. Acanthamoeba keratitis: diagnosis and treatment update 2009. American Journal of Ophthalmology 2009;148(4):487-99.
19. Garate M, Marchant J, Cubillos I, Cao Z, Khan NA, Panjwani N. In vitro pathogenicity of Acanthamoeba is associated with the expression of the mannose-binding protein. Investigative Ophthalmology and Visual Science 2006;47(3):1056-62.
20. Glanville JM, Lefebvre C, Miles JN, Camosso-Stefinovic J. How to identify randomized controlled trials in MEDLINE: ten years on. Journal of the Medical Library Association 2006;94(2):130-6.
21. Gray TB, Cursons RT, Sherwan JF, Rose PR. Acanthamoeba, bacterial, and fungal contamination of contact lens storage cases. British Journal of Ophthalmology 1995;79(6):601-5.
22. Hammersmith KM. Diagnosis and management of Acanthamoeba keratitis. Current Opinion in Ophthalmology 2006;17(4):327-31.
23. Hay J, Kirkness CM, Seal DV, Wright P. Drug resistance and Acanthamoeba keratitis: the quest for alternative antiprotozoal chemotherapy. Eye 1994;8(Pt 5):555-63.
24. Herz NL, Matoba AY, Wilhelmus KR. Rapidly progressive cataract and iris atrophy during treatment of Acanthamoeba keratitis. Ophthalmology 2008;115(5):866-9.
25. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
26. Hiti K, Walochnik J, Faschinger C, Haller-Schober EM, Aspöck H. One- and two-step hydrogen peroxide contact lens disinfection solutions against Acanthamoeba: how effective are they?. Eye 2005;19(12):1301-5.
27. Ibrahim YW, Boase DL, Cree IA. Factors affecting the epidemiology of Acanthamoeba keratitis. Ophthalmic Epidemiology 2007;14(2):53-60.
28. Johnston SP, Sriram R, Qvarnstrom Y, Roy S, Verani J, Yoder J, et al. Resistance of Acanthamoeba cysts to disinfection in multiple contact lens solutions. Journal of Clinical Microbiology 2009;47(7):2040-5.
29. Kilvington S, Gray T, Dart J, Morlet N, Beeching JR, Frazer DG, et al. Acanthamoeba keratitis: the role of domestic tap water contamination in the United Kingdom. Investigative Ophthalmology and Visual Science 2004;45(1):165-9.
30. Kim EC, Kim MS. Bilateral acanthamoeba keratitis after orthokeratology. Cornea 2010;29(6):680-2.
31. Lehmann OJ, Green SM, Morlet N, Kilvington S, Keys MF, Matheson MM, et al. Polymerase chain reaction analysis of corneal epithelial and tear samples in the diagnosis of Acanthamoeba keratitis. Investigative Ophthalmology and Visual Science 1998;39(7):1261-5.
32. Lindsay RG, Watters G, Johnson R, Ormonde SE, Snibson GR. Acanthamoeba keratitis and contact lens wear. Clinical and Experimental Optometry 2007;90(5):351-60.
33. Mathers WD, Goldberg MA, Sutphin JE, Ditkoff JW, Folberg R. Coexistent Acanthamoeba keratitis and herpetic keratitis. Archives of Ophthalmology 1997;115(6):714-8.
34. Matoba AY, Pare PD, Le TD, Osato MS. The effects of freezing and antibiotics on the viability of Acanthamoeba cysts. Archives of Ophthalmology 1989;107(3):439-40.
35. Murthy S, Hawksworth NR, Cree I. Progressive ulcerative keratitis related to the use of topical chlorhexidine gluconate (0.02%). Cornea 2002;21(2):237-9.
36. Naginton J, Watson PG, Playfair TJ, McGill J, Jones BR, Steele AD. Amoebic infection of the eye. Lancet 1974;2(7896):1537-40.
37. Neff RJ, Neff RH. The biochemistry of amoebic encystment. Symposia of the Society for Experimental Biology 1969;23:51-81.
38. Oh JY, Lee HJ, Khwarg SI, Wee WR. Corneal cell viability and structure after transcorneal freezing-thawing in the human cornea. Clinical Ophthalmology 2010;4:477-80.
39. Park JT, Jeong YE, Ahn TI. Changes in profiles of major proteins in encysting Acanthamoeba castellanii. Korean Journal of Biological Sciences 2002;6(4):341-7.
40. Pérez-Santonja JJ, Kilvington S, Hughes R, Tufail A, Matheson M, Dart JK. Persistently culture positive acanthamoeba keratitis: in vivo resistance and in vitro sensitivity. Ophthalmology 2003;110(8):1593-600.
41. Radford CF, Minassian DC, Dart JK. Acanthamoeba keratitis in England and Wales: incidence, outcome, and risk factors. British Journal of Ophthalmology 2002;86(5):536-42.
42. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
43. Rezaei Kanavi M, Naghshgar N, Javadi MA, Sadat Hashemi M. Various confocal scan features of cysts and trophozoites in cases with Acanthamoeba keratitis. European Journal of Ophthalmology 2012;22(Suppl 7):S46-50.
44. Robaei D, Carnt N, Minassian DC, Dart JK. Therapeutic and optical keratoplasty in the management of Acanthamoeba keratitis: risk factors, outcomes, and summary of the literature. Ophthalmology 2015;122(1):17-24.
45. Ross J, Roy SL, Mathers WD, Ritterband DC, Yoder JS, Ayers T, et al. Clinical characteristics of Acanthamoeba keratitis infections in 28 states, 2008 to 2011. Cornea 2014;33(2):161-8.
46. Seal DV, Dalton A, Doris D. Disinfection of contact lenses without tap water rinsing: is it effective?. Eye 1999;13(Pt 2):226-30.
47. Seal D. Treatment of Acanthamoeba keratitis. Expert Review of Anti-infective Therapy 2003;1(2):205-8.
48. Seal DV. Acanthamoeba keratitis update-incidence, molecular epidemiology and new drugs for treatment. Eye 2003;17(8):893-905.
49. Sharma S, Garg P, Rao GN. Patient characteristics, diagnosis, and treatment of non-contact lens related Acanthamoeba keratitis. British Journal of Ophthalmology 2000;84(10):1103-8.
50. Speer CE, Hofmeister EM, Cohen EJ. An atypical presentation of Acanthamoeba keratitis in a noncontact lens wearer. Eye Contact Lens 2003;29(1):21-2.
51. Stehr-Green JK, Bailey TM, Brandt FH, Carr JH, Bond WW, Visvesvara GS. Acanthamoeba keratitis in soft contact lens wearers. A case-control study. JAMA 1987;258(1):57-60.
52. Stehr-Green JK, Bailey TM, Visvesvara GS. The epidemiology of Acanthamoeba keratitis in the United States. American Journal of Ophthalmology 1989;107(4):331-6.
53. Sun X, Zhang Y, Li R, Wang Z, Luo S, Gao M, et al. Acanthamoeba keratitis: clinical characteristics and management. Ophthalmology 2006;113(3):412-6.
54. Drugs for parasitic infections. www.cdc.gov/parasites/acanthamoeba/resources/acanthamoeba_keratitis.pdf (accessed 16 December 2014).
55. Thebpatiphat N, Hammersmith KM, Rocha FN, Rapuano CJ, Ayres BD, Laibson PR, et al. Acanthamoeba keratitis: a parasite on the rise. Cornea 2007;26(6):701-6.
56. Tu EY, Joslin CE, Sugar J, Shoff ME, Booton GC. Prognostic factors affecting visual outcome in Acanthamoeba keratitis. Ophthalmology 2008;115(11):1998-2003.
57. Tuft S, Burton M. Focus Autumn 2013 - The Royal College of Ophthalmologists. Microbial keratitis. www.rcophth.ac.uk/core/core_picker/download.asp?id=1826 (accessed 15 October 2014).
58. US Department of Health and Human Services, Public Health Service. Acanthamoeba keratitis associated with contact lenses-United States. Morbidity and Mortality Weekly Report 1986;35(25):405-8.
59. Vaddavalli PK, Garg P, Sharma S, Sangwan VS, Rao GN, Thomas R. Role of confocal microscopy in the diagnosis of fungal and acanthamoeba keratitis. Ophthalmology 2011;118(1):29-35.
60. Walochnik J, Haller-Schober E, Kölli H, Picher O, Obwaller A, Aspöck H. Discrimination between clinically relevant and nonrelevant Acanthamoeba strains isolated from contact lens-wearing keratitis patients in Austria. Journal of Clinical Microbiology 2000;38(11):3932-6.
61. Watson S, Dart J. Section 3: 16c. Acanthamoeba keratitis. In: Johnson GJ, Minassian DC, Weale RA, West SK editor(s). The Epidemiology of Eye Disease. 3rd Edition. Imperial College Press, 2012.
62. Watt K, Swarbrick HA. Microbial keratitis in overnight orthokeratology: review of the first 50 cases. Eye Contact Lens 2005;31(5):201-8.
63. Winchester K, Mathers WD, Sutphin JE, Daley TE. Diagnosis of Acanthamoeba keratitis in vivo with confocal microscopy. Cornea 1995;14(1):10-7.
64. Wright P, Warhurst D, Jones BR. Acanthamoeba keratitis successfully treated medically. British Journal of Ophthalmology 1985;69(10):778-82.
65. Yoder JS, Verani J, Heidman N, Hoppe-Bauer J, Alfonso EC, Miller D, et al. Acanthamoeba keratitis: the persistence of cases following a multistate outbreak. Ophthalmic Epidemiology 2012;19(4):221-5.
66. Alkharashi M, Lindsley K, Sikder S. Medical interventions for acanthamoeba keratitis. Cochrane Database of Systematic Reviews 2013, Issue 10. [DOI: 10.1002/14651858.CD010792]